Vasculitis Dementia refers to cognitive impairment and dementia resulting from cerebral vasculitis—inflammation and damage to the blood vessels of the brain[@calabrese1988]. This condition represents a potentially treatable cause of dementia, as opposed to the more common neurodegenerative dementias. Cerebral vasculitis (also known as angiitis) can affect vessels of any size and lead to ischemic damage, hemorrhage, and progressive cognitive decline.
Classification of Cerebral Vasculitis
Primary CNS Vasculitis
Primary Angiitis of the CNS (PACNS)
Isolated inflammation of brain vessels with no systemic involvement
Also called primary angiitis of the central nervous system
Drug-induced: Cocaine, amphetamines, certain medications
Pathophysiology
Mechanisms of Brain Damage
...
Vasculitis Dementia
Overview
Vasculitis Dementia refers to cognitive impairment and dementia resulting from cerebral vasculitis—inflammation and damage to the blood vessels of the brain[@calabrese1988]. This condition represents a potentially treatable cause of dementia, as opposed to the more common neurodegenerative dementias. Cerebral vasculitis (also known as angiitis) can affect vessels of any size and lead to ischemic damage, hemorrhage, and progressive cognitive decline.
Classification of Cerebral Vasculitis
Primary CNS Vasculitis
Primary Angiitis of the CNS (PACNS)
Isolated inflammation of brain vessels with no systemic involvement
Also called primary angiitis of the central nervous system
Cyclophosphamide: Induction therapy, 2-4 mg/kg IV or oral
Azathioprine: Maintenance, 2-2.5 mg/kg/day
Mycophenolate mofetil: Alternative maintenance
Methotrexate: Alternative maintenance (avoid in renal involvement)
Biologic Agents
Rituximab: For ANCA-associated vasculitis
Tocilizumab: For refractory cases
Infliximab: TNF-alpha inhibitor in severe cases
Antiplatelet/Anticoagulation
Low-dose aspirin: May help prevent thrombosis
Anticoagulation: Generally avoided due to hemorrhage risk
Symptomatic Management
Cognitive rehabilitation: Occupational therapy
Seizure control: Antiepileptic medications
Mood stabilization: Antidepressants as needed
Pain management: For headaches
Treatment Response
Clinical improvement: Often within weeks to months
Radiographic improvement: May lag behind clinical response
Relapse risk: 25-40% in first 5 years
Maintenance therapy: Often needed for 2-3 years
Prognosis
Factors Influencing Outcome
Early treatment: Critical for better outcomes
Extent of disease: Diffuse involvement worse prognosis
Age: Younger patients generally do better
Treatment response: Early responders have better outcomes
Outcomes
Complete recovery: Possible in 30-40% with early treatment
Partial recovery: Common, with residual deficits
Progression despite treatment: 20-30% have ongoing disease
Mortality: 10-20% mortality, often due to infection or disease complications
Conclusion
Vasculitis dementia represents an important potentially reversible cause of cognitive impairment. Prompt recognition and aggressive immunosuppressive treatment can lead to significant recovery in many cases. The key to diagnosis is maintaining a high index of suspicion in patients with subacute cognitive decline, particularly when associated with headache, seizures, or other focal neurological symptoms. Multidisciplinary management involving neurologists, rheumatologists, and radiologists is essential for optimal care.
[Calabrese LH, Mallek JA, Primary angiitis of the central nervous system: report of 8 new cases, review of the literature, and proposal for diagnostic criteria (1988)](https://pubmed.ncbi.nlm.nih.gov/3276980/)